Literature DB >> 21424067

Nuclear comparative morphometric study between DCIS and normal resting mammary gland tissue.

Mariana Deacu1, Mariana Aşchie, Mădălina Boşoteanu, L Petcu.   

Abstract

Ductal carcinoma in situ (DCIS) is the malignant epithelial cell proliferation that affect only ducts, including lobular, without basement membrane interruption. Benign or malignant cell phenotype is defined by nuclear appearance. Morphometric analysis could provide quantitative information about nuclear profile in several lesions. In this study, we assess nuclear morphometric features of mammary epithelial cells in DCIS compared to normal resting mammary gland tissue. For morphological evaluation, we included two groups of mammary gland tissue. The first group comprised breast tissue from 20 women surgically treated and histopathologically confirmed with DCIS. The second control group was represented by normal resting mammary tissue obtained from another 20 women surgically treated for fibroadenoma. Evaluated morphometric parameters were: nuclear area (NA), nuclear perimeter (P), maximum diameter (Dmax), minimum diameter (Dmin), elongation factor (E). Morphometric assessment of DCIS nuclei showed significant higher values than normal resting breast tissue. Morphometric analysis gave information about tumor aggressiveness, invasion tendency and disease prognostic.

Entities:  

Mesh:

Year:  2011        PMID: 21424067

Source DB:  PubMed          Journal:  Rom J Morphol Embryol        ISSN: 1220-0522            Impact factor:   1.033


  2 in total

1.  Noninvasive evaluation of nuclear morphometry in breast lesions using multispectral diffuse optical tomography.

Authors:  Mohammad Reza Hajihashemi; Stephen R Grobmyer; Samer Z Al-Quran; Huabei Jiang
Journal:  PLoS One       Date:  2012-09-19       Impact factor: 3.240

2.  Carnegie Mellon University bioimaging day 2014: Challenges and opportunities in digital pathology.

Authors:  Gustavo K Rohde; John A Ozolek; Anil V Parwani; Liron Pantanowitz
Journal:  J Pathol Inform       Date:  2014-08-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.